Oderup Cecilia, Malm Helene, Ekberg Henrik, Qi Zhongquan, Veress Béla, Ivars Fredrik, Corbascio Matthias
Section for Immunology, Lund University, Lund, Sweden.
Transplantation. 2006 Dec 15;82(11):1493-500. doi: 10.1097/01.tp.0000244064.66136.04.
Previous studies have demonstrated that anti-CD40L or anti-B7 requires the presence of CD4(+)CD25(+) regulatory T cells (Treg) to induce antigen specific hyporesponsiveness. Other tolerance strategies involving Treg have shown a dependency on interleukin (IL)-10. The objective of this study was to investigate the role of CD4(+)CD25(+) Treg and IL-10 when treating transplant recipients with cytotoxic T lymphocyte-associated antigen (CTLA)-4 immunoglobulin (Ig), anti-CD40L, and anti-lymphocyte function-associated antigen (LFA)-1.
Recombinase activating gene-deficient (Rag1(-/-) mice were transplanted with BALB/c hearts and adoptively transferred with IL-10(-/-) CD4(+) T cells, CD4(+)CD25(-) T cells or CD4(+)CD25(-)CD103(-) T cells and treated with costimulation blockade. Intragraft T cells from C57BL/6 recipients were analyzed for the expression of the Foxp3 protein after tolerance induction.
Mice reconstituted with IL-10(-/-) CD4(+) T cells, CD4(+)CD25(-) T cells or CD4(+)CD25(-) CD103(-) T cells and treated with costimulation blockade accepted allografts permanently. Analysis of cells from recipient mice adoptively transferred with CD4(+)CD25(-) T cells contained a population of CD4(low)CD25(+) T cells 100 days after transplantation. Costimulation blockade partially prevented the homeostatic proliferation of CD4(+)CD25(-)CD103(-) T cells in Rag-1(-/-) recipients. Accepted allografts contained an elevated number of CD4(+)Foxp3(+) T cells.
These results indicate that T-cell derived IL-10 is not essential for induction of graft acceptance in mice treated with costimulation blockade, but that treatment limits T-cell expansion in the recipients. The results further indicate that tolerance is maintained by intragraft CD4(+)Foxp3(+) T cells.
既往研究表明,抗CD40L或抗B7需要CD4(+)CD25(+)调节性T细胞(Treg)的存在才能诱导抗原特异性低反应性。其他涉及Treg的耐受策略已显示出对白介素(IL)-10的依赖性。本研究的目的是探讨在用细胞毒性T淋巴细胞相关抗原(CTLA)-4免疫球蛋白(Ig)、抗CD40L和抗淋巴细胞功能相关抗原(LFA)-1治疗移植受者时,CD4(+)CD25(+) Treg和IL-10的作用。
将重组激活基因缺陷(Rag1(-/-))小鼠移植BALB/c心脏,并过继转移IL-10(-/-) CD4(+) T细胞、CD4(+)CD25(-) T细胞或CD4(+)CD25(-)CD103(-) T细胞,并用共刺激阻断进行治疗。对C57BL/6受者的移植内T细胞在诱导耐受后分析Foxp3蛋白的表达。
用IL-10(-/-) CD4(+) T细胞、CD4(+)CD25(-) T细胞或CD4(+)CD25(-) CD103(-) T细胞重建并用共刺激阻断治疗的小鼠永久性地接受了同种异体移植物。对移植后100天过继转移CD4(+)CD25(-) T细胞的受者小鼠的细胞分析显示,含有一群CD4(low)CD25(+) T细胞。共刺激阻断部分阻止了Rag-1(-/-)受者中CD4(+)CD25(-)CD103(-) T细胞的稳态增殖。被接受的同种异体移植物中CD4(+)Foxp3(+) T细胞数量增加。
这些结果表明,T细胞来源的IL-10在用共刺激阻断治疗的小鼠诱导移植物接受中并非必需,但该治疗限制了受者中的T细胞扩增。结果还表明,耐受由移植内CD4(+)Foxp3(+) T细胞维持。